Arthrex ACP® Double Syringe

ACP - Autologous Conditioned Plasma

Autologous Conditioned Plasma

Introduction

Autologous blood products have created a growing interest for use in a number of therapies. The healing effects of plasma are supported by growth factors released by platelets. These growth factors induce a healing process wherever they are applied.

Features and Benefits

• The ACP (Autologous Conditioned Plasma) double syringe allows rapid and efficient concentration of platelets and growth factors from autologous blood, for use at the treatment site.

• The unique double syringe design allo ws a convenient and safe handling, as the whole preparation process takes place in a closed system.

• The ACP System is more affordable, easier to use, and has a quicker procedure time when compared to other conventional PRP (platelet-rich plasma) devices.

• White and red blood cells are not concentr ated within the ACP system. These cells can cause a detrimental effect on the healing process due to release of degradative proteins and reactive oxygen species.

Clinical and Surgical Applications

Intra-tendonous Therapy

Acute or chronic tendonitis and tendonopathy can be treated with PRP injections. PRP can also be used to a ugment any tendon repair procedure intraoperatively. PRP has been demonstr ated to increase anabolic and extr acellular matrix gene expression, induce cell proliferation, improve neovascularization, advance range of motion, and promote early reco very through a number of in vitro, in vivo and clinical studies with respect to tendon therapies.

Intra-articular Therapy

PRP has shown some significant promise with respect to intra-articular therapy for treatment of cartilage, the meniscus and the disease of osteoarthritis. Studies have been able to describe PRP as a method to increase c hondrocyte extracellular matrix production, synovial hyaluronic acid production and impro ve patient pain/function for osteoarthritis.  Osteoarthritis is a catastrophic joint disease that sev erely affects clients within v eterinary practices. Having the potential to pro vide an autologous therapeutic solution to help remedy pain associated with this disease becomes an advantageous option.